Health Wire East Timor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire East Timor.

Press releases published on March 30, 2026

Mar. 30, 2026

Invivyd Announces Presentation at the World Vaccine Congress Washington

Indeterminate GlobeNewswire

Mar. 30, 2026

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Mar. 30, 2026

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

Indeterminate GlobeNewswire

Mar. 30, 2026

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Indeterminate GlobeNewswire

Mar. 30, 2026

Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 30, 2026

Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million

Indeterminate GlobeNewswire

Mar. 30, 2026

RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 30, 2026

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

Indeterminate GlobeNewswire

Mar. 30, 2026

Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 30, 2026

Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 30, 2026

Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease

Indeterminate GlobeNewswire

Mar. 30, 2026

Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results

Indeterminate GlobeNewswire

Mar. 30, 2026

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

Indeterminate GlobeNewswire

Mar. 30, 2026

INmune Bio Inc. Announces 2025 Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 30, 2026

Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54

Indeterminate GlobeNewswire

Mar. 30, 2026

Children’s National Hospital announces new pain management center to help children and their families reclaim their lives from chronic pain

Indeterminate GlobeNewswire

Mar. 30, 2026

UPDATE - National Healthcare Leaders Call for Radical System Transformation at TEDxNightingale College Event

Indeterminate GlobeNewswire

Mar. 30, 2026

Medicine and Money Show Launches New Book and Free Global Financial Education Hub for Doctors

Indeterminate GlobeNewswire

Mar. 30, 2026

Major Shareholder Announcement

Indeterminate GlobeNewswire

Mar. 30, 2026

Supported by significant progress in the financing of its industrial project in France, Carbios confirms its objective to build the Longlaville plant

Indeterminate GlobeNewswire